These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 8246167)

  • 21. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide.
    Suarez-Roca H; Lovenberg T; Cubeddu LX
    J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats.
    Xu K; Dluzen DE
    J Neural Transm (Vienna); 1996; 103(11):1295-305. PubMed ID: 9013416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of amiloride and 5-(N,N-hexamethylene)amiloride on dopaminergic and cholinergic neurotransmission.
    Zubieta JK; Cragoe EJ; Cubeddu LX
    J Pharmacol Exp Ther; 1988 Oct; 247(1):88-95. PubMed ID: 2845061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term survival of intrastriatal dopaminergic grafts: modulation of acetylcholine release by graft-derived dopamine.
    Jackisch R; Duschek M; Neufang B; Rensing H; Hertting G; Herman JP
    J Neurochem; 1991 Jul; 57(1):267-76. PubMed ID: 2051168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thalamic regulation of striatal acetylcholine efflux is both direct and indirect and qualitatively altered in the dopamine-depleted striatum.
    Zackheim J; Abercrombie ED
    Neuroscience; 2005; 131(2):423-36. PubMed ID: 15708484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transmitter release by non-receptor activation of the alpha-subunit of guanine nucleotide regulatory protein in rat striatal slices.
    Zelles T; Chernaeva L; Baranyi M; Déri Z; Adam-Vizi V; Vizi ES
    J Neurosci Res; 1995 Oct; 42(2):242-51. PubMed ID: 8568925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
    Wachtel SR; Abercrombie ED
    J Neurochem; 1994 Jul; 63(1):108-17. PubMed ID: 8207420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats.
    Buck K; Ferger B
    Neurobiol Dis; 2008 Feb; 29(2):210-20. PubMed ID: 17920284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats.
    Miller DW; Abercrombie ED
    J Neurochem; 1999 Apr; 72(4):1516-22. PubMed ID: 10098856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.
    Treseder SA; Rose S; Jenner P
    Eur J Neurosci; 2001 Jan; 13(1):162-70. PubMed ID: 11135014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia.
    Lee J; Zhu WM; Stanic D; Finkelstein DI; Horne MH; Henderson J; Lawrence AJ; O'Connor L; Tomas D; Drago J; Horne MK
    Brain; 2008 Jun; 131(Pt 6):1574-87. PubMed ID: 18487277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine.
    Meissner W; Ravenscroft P; Reese R; Harnack D; Morgenstern R; Kupsch A; Klitgaard H; Bioulac B; Gross CE; Bezard E; Boraud T
    Neurobiol Dis; 2006 Jun; 22(3):586-98. PubMed ID: 16531050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
    Miller DK; Sumithran SP; Dwoskin LP
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals.
    Hoffmann IS; Talmaciu RK; Ferro CP; Cubeddu LX
    J Pharmacol Exp Ther; 1988 Jun; 245(3):761-72. PubMed ID: 3385641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
    Robertson GS; Tham CS; Wilson C; Jakubovic A; Fibiger HC
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1344-51. PubMed ID: 8095550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats.
    Carta M; Lindgren HS; Lundblad M; Stancampiano R; Fadda F; Cenci MA
    J Neurochem; 2006 Mar; 96(6):1718-27. PubMed ID: 16539687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.
    Cenci MA; Lee CS; Björklund A
    Eur J Neurosci; 1998 Aug; 10(8):2694-706. PubMed ID: 9767399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats.
    Tanaka H; Kannari K; Maeda T; Tomiyama M; Suda T; Matsunaga M
    Neuroreport; 1999 Feb; 10(3):631-4. PubMed ID: 10208602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of dopamine synthesis in the medial prefrontal cortex: studies in brain slices.
    Wolf ME; Galloway MP; Roth RH
    J Pharmacol Exp Ther; 1986 Mar; 236(3):699-707. PubMed ID: 2869140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K; Dziubina A
    Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.